ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,074Medicare Part D Prescriptions Filled, Including Refills

Rank: 138 out of 973

$525K Total Retail Price of All Prescriptions

Rank: 129 out of 973

322 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 322 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 322 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 7,689 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
SIMVASTATIN 462 392 1 1
LEVOTHYROXINE SODIUM 370 306 2 2
LISINOPRIL 369 296 3 3
FUROSEMIDE 315 275 4 6
OMEPRAZOLE 296 243 5 5
POTASSIUM CHLORIDE 236 169 6 9
METFORMIN HCL 208 171 7 8
SERTRALINE HCL 206 177 8 21
AMLODIPINE BESYLATE 193 160 9 7
ATORVASTATIN CALCIUM 172 131 10 15
HYDROCHLOROTHIAZIDE 172 114 10 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 149 110 12 25
METFORMIN HCL ER 146 142 13 58
ATENOLOL 134 109 14 16
DONEPEZIL HCL 127 126 15 26
HYDROCODONE-ACETAMINOPHEN 119 104 S3 16 4
METOPROLOL SUCCINATE 118 82 17 17
WARFARIN SODIUM 114 94 18 10
PANTOPRAZOLE SODIUM 113 84 19 37
FLUTICASONE PROPIONATE 108 65 20 35
ONGLYZA 107 88 21 250
LOSARTAN POTASSIUM 106 90 22 19
TAMSULOSIN HCL 100 68 23 28
JANUVIA 100 66 23 88
MELOXICAM 94 54 25 23
TRIAMTERENE-HCTZ 91 61 26 51
KLOR-CON M20 90 86 27 64
NEXIUM 89 55 28 30
TRAMADOL HCL 85 81 29 18
ALLOPURINOL 84 61 30 29
SPIRONOLACTONE 84 60 30 49
POLYETHYLENE GLYCOL 3350 83 58 32 36
METOPROLOL TARTRATE 82 65 33 13
GABAPENTIN 81 72 34 12
TRAZODONE HCL 79 38 35 48
GLIMEPIRIDE 79 73 35 41
AMLODIPINE BESYLATE-BENAZEPRIL 76 65 37 80
CYMBALTA 71 26 38 40
CRESTOR 70 48 39 34
IPRATROPIUM-ALBUTEROL 69 65 40 115
NAMENDA 68 68 41 31
VESICARE 68 41 41 133
ZOLPIDEM TARTRATE 67 67 43 20
METOCLOPRAMIDE HCL 67 26 43 93
PREDNISONE 65 50 45 33
JANTOVEN 64 64 46 113
CLONIDINE HCL 64 55 46 67
RANITIDINE HCL 62 47 48 45
PRAVASTATIN SODIUM 61 46 49 22
FINASTERIDE 59 45 50 90
CYCLOBENZAPRINE HCL 57 38 R 51 42
BYSTOLIC 56 42 52 110
DIGOXIN 56 56 52 32
SINGULAIR 53 37 54 106
LEVOFLOXACIN 53 39 54 84
LOSARTAN-HYDROCHLOROTHIAZIDE 51 50 56 46
ROPINIROLE HCL 51 30 56 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 25, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.